Tag: Singapore eDevelopment Ltd
Impact Biomedical initiates Quantum Research Program to solve the Patent Cliff
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. ("Impact"), announced today the initiation of Quantum, their research program designed...
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that their COVID-19 research with Global...
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at...
SGX-listed Singapore eDevelopment Limited's (the "Company") (SeD; SGX:40V) wholly owned subsidiary, Impact Biomedical Inc. ("Impact Biomedical"), would like to update its stakeholders...
